Law360, New York (September 29, 2009, 4:46 PM ET) -- Eli Lilly & Co. is set to fork over $25.1 million to settle a lawsuit brought by the Connecticut Attorney General's Office for allegedly marketing its antipsychotic Zyprexa for unapproved uses and concealing the drug's serious side effects for more than a decade.
The settlement, announced Tuesday by Connecticut Attorney General Richard Blumenthal, marks the third such deal the pharmaceutical giant has brokered with states in recent months.
Lilly reached the deal without admitting any wrongdoing, according to a consent decree filed Tuesday in the U.S....
Lilly To Pay Conn. $25M Over Zyprexa Marketing
To view the full article, take a free trial now.
